When you click on links to various merchants on this site and make a purchase, this can result in this site earning a commission. Affiliate programs and affiliations include, but are not limited to, the eBay Partner Network.
Up for sale "Tumor Biology" Rakesh Jain Hand Signed Album Page Dated 1982.
ES-7948E
Rakesh
K. Jain is the Andrew
Werk Cook Professor of Tumor Biology at Massachusetts General
Hospital in the Harvard Medical School and
Director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts
General Hospital. He has
mentored more than 200 graduate and postdoctoral students from over a dozen
different disciplines. Jain's research findings are summarized in more than 600
publications, which have been cited more than 70,000 times (as of December,
2015). He was among the top 1% cited researchers in Clinical Medicine in
2014-15. He serves or has served on advisory panels to
government, industry and academia, and is a member of editorial advisory boards
of 22 journals, including Nature Reviews Cancer and Nature Reviews Clinical
Oncology. He has received more than 75 awards from engineering and medical
professional societies/institutions. He was elected a member of the National Academy of
Engineering in 2004 for the integration of bioengineering with
tumor biology and imaging gene expression and functions in vivo for drug
delivery in tumors. He is also a member of the National Academy of Medicine,
the National Academy of Sciences and the American
Academy of Arts and Sciences. In 2014, he was chosen as one of 50
Oncology Luminaries on the occasion of the 50th anniversary of the American
Society of Clinical Oncology. In 2015, Jain received honorary doctorates
from Duke University, KU Leuven, Belgium and IIT-Kanpur, India. In 2013, he was
awarded the National Medal of Science. Jain received his bachelor's degree in 1972
from IIT Kanpur, and his MS and PhD degrees in 1974 and 1976 from the
University of Delaware, all in chemical engineering. He served as assistant
professor of chemical engineering at Columbia University (1976 to 1978), and as
assistant (1978–79), associate (1979–83) and full professor (1983-1991) of
chemical engineering at Carnegie Mellon University. He spent his 1983-84
sabbatical year as a Guggenheim Fellow in the departments of chemical
engineering at MIT, bioengineering at UCSD and radiation oncology at Stanford,
and his 1990-91 sabbatical as a Humboldt Senior Scientist-Awardee at the
Institute of Pathophysiology of University of Mainz, and the Institute of
Experimental Surgery of University of Munich. In 1991, Jain became the Andrew
Werk Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School,
and Director of Edwin L. Steele Laboratories of Tumor Biology at Massachusetts General
Hospital. Jain is regarded as a pioneer in the area of tumor
microenvironment and widely recognized for his seminal discoveries in tumor
biology, drug delivery, in vivo imaging, bioengineering, and bench-to-bedside
translation. These include uncovering the barriers to the delivery and efficacy
of molecular and nano-medicines in tumors, developing new strategies to
overcome these barriers, and then translating these strategies from bench to
bedside. He is most celebrated for proposing a new principle – normalization of
vasculature – for treatment of malignant and non-malignant diseases
characterized by abnormal vessels that afflict more than 500 million people
worldwide. This concept has fundamentally changed the thinking of scientists
and clinicians about how antiangiogenic agents work, and how to combine them
optimally with other therapies to improve the treatment outcome in patients.
